Silo Pharma (NASDAQ: SILO) received a Notice of Allowance from the U.S. Patent and Trademark Office for a key patent supporting its lead asset, SPC- ...

SSDP and the government agreed there is no evidence of physiological or psychic dependence or documentation of human use in ...